What happened
JW Holdings updated a previously disclosed supply contract with GLAND PHARMA LIMITED, now worth US$19M, about 4.17% of its recent annual revenue.
For context, this single contract equals about 4.17% of the company's most recent annual revenue.
| Counterparty | GLAND PHARMA LIMITED |
|---|---|
| Contract value | US$19M |
| vs. recent revenue | 4.17% |
| Through | N/A |
| Filed | 2026-03-26, [Amended] Supply contract signed (voluntary) |
| Source | DART rcept 20260326803402 → open original filing |
Source: DART. Information only, not investment advice.